Character Biosciences Funding: $128M Raised, Series B (2024)
Character Biosciences is based in San Francisco. It has raised $128M in total funding. Latest round: Series B.
Character Biosciences funding overview
Character Biosciences is based in San Francisco. Character Biosciences has raised $128M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for Character Biosciences runs through 2024; nothing later has been disclosed. Investors on record include aMoon Growth Fund, Luma Group, Bausch + Lomb, Innovation Endeavors, Catalio Capital Management, Sanofi Ventures and 6 others. 12 distinct backers are named across the disclosed rounds.
Character Biosciences at a glance
Total raised
$128M
Latest round
Series B
Latest round date
January 2024
Headquarters
San Francisco
Notable investors
aMoon Growth Fund, Luma Group, Bausch + Lomb, Innovation Endeavors, Catalio Capital Management, Sanofi Ventures, Section 32, LifeForce Capital
Frequently asked about Character Biosciences funding
How much has Character Biosciences raised?
Character Biosciences has raised $128M in total disclosed funding across the rounds on record.
Who has invested in Character Biosciences?
aMoon Growth Fund, Luma Group, Bausch + Lomb, Innovation Endeavors, Catalio Capital Management, Sanofi Ventures are named among the investors backing Character Biosciences.
What was the latest Character Biosciences funding round?
The most recent disclosed round is a Series B, announced in January 2024.
Where is Character Biosciences based?
Character Biosciences is based in San Francisco.
When did Character Biosciences last raise?
The last disclosed Character Biosciences round closed in January 2024 at Series B.
Totals shown for Character Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in San Francisco and the investors behind them below.
